Stocks · Health care · Biological Products, (No Diagnostic Substances)

Amgen

AMGN Clue Score50
United States Fiscal year ends December CIK 0000318154 Results filed 3 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Rachna Khosla
13 Aug 2026
SVP, Business Development
Sold after exercise
1,252
$416.43
$521.36K
Rachna Khosla
11 Aug 2026
SVP, Business Development
Sell
2,000
$412.57
$825.13K
Nancy A. Grygiel
6 Aug 2026
SVP & CCO
Sold after exercise
1,000
$402.16
$402.16K
Nancy A. Grygiel
6 Aug 2026
SVP & CCO
Sold after exercise
1,970
$402.16
$792.26K
Derek Miller
6 Aug 2026
SVP, Human Resources
Sold after exercise
1,821
$402.54
$733.03K
Derek Miller
6 Aug 2026
SVP, Human Resources
Sold after exercise
2,069
$402.54
$832.86K
Nancy A. Grygiel
4 May 2026
SVP & CCO
Sell
1,237
$323.73
$400.45K
Robert A Bradway
4 Mar 2026
Chairman, CEO and President
Exercised, kept
119,782
$156.35
$18.73M
Esteban Santos
26 Feb 2026
EVP, Operations
Sold after exercise
24,291
$379.12
$9.21M
Esteban Santos
26 Feb 2026
EVP, Operations
Sold after exercise
30,501
$379.12
$11.56M
Matthew C. Busch
19 Feb 2026
VP, Finance & CAO
Sell
1,000
$375.79
$375.79K
Nancy A. Grygiel
20 Nov 2025
SVP & CCO
Sold after exercise
1,639
$337.26
$552.77K
Nancy A. Grygiel
20 Nov 2025
SVP & CCO
Sold after exercise
1,500
$337.26
$505.89K
Murdo Gordon
12 Nov 2025
EVP, Global Commercial Ops
Sell
6,879
$336.83
$2.32M
Rachna Khosla
12 Nov 2025
SVP, Business Development
Sell
890
$336.24
$299.26K
Nancy A. Grygiel
20 Aug 2025
SVP & CCO
Sell
1,267
$296.99
$376.28K
Rachna Khosla
5 Jun 2025
SVP, Business Development
Sell
1,500
$289.68
$434.52K
Matthew C. Busch
2 May 2025
VP, Finance & CAO
Sell
1,000
$279.69
$279.69K
David M Reese
21 Feb 2025
EVP & Chief Technology Officer
Sell
25,225
$304.44
$7.68M
Derek Miller
19 Feb 2025
SVP, Human Resources
Sold after exercise
1,524
$293.74
$447.65K
David M Reese
19 Feb 2025
EVP & Chief Technology Officer
Sold after exercise
8,711
$293.22
$2.55M
Esteban Santos
19 Feb 2025
EVP, Operations
Sold after exercise
8,711
$292.84
$2.55M
Derek Miller
18 Feb 2025
SVP, Human Resources
Sell
500
$292.56
$146.28K
Murdo Gordon
11 Feb 2025
EVP, Global Commercial Ops
Sell
8,771
$294.79
$2.59M
Jonathan P Graham
7 Feb 2025
EVP & Gen. Counsel & Secy.
Sold after exercise
25,045
$293.12
$7.34M
Nancy A. Grygiel
5 Feb 2025
SVP & CCO
Sell
1,589
$304.47
$483.81K
Nancy A. Grygiel
3 May 2024
SVP & CCO
Sell
2,117
$313.09
$662.80K
Nancy A. Grygiel
4 Dec 2023
SVP & CCO
Sell
2,096
$273.03
$572.28K
Jonathan P Graham
8 Nov 2023
EVP, Gen. Counsel & Secy.
Sell
10,000
$272.81
$2.73M
Murdo Gordon
10 Aug 2023
EVP, Global Commercial Ops
Sell
9,558
$262.43
$2.51M
Rachna Khosla
9 Nov 2022
SVP, Business Development
Sell
387
$292.90
$113.35K
Nancy A. Grygiel
8 Nov 2022
SVP & CCO
Sell
545
$293.54
$159.98K
R Sanders Williams
22 Aug 2022
Director
Sell
200
$249.96
$49.99K
Robert Eckert
18 Aug 2022
Director
Sell
6,600
$249.00
$1.64M
Robert Eckert
10 Aug 2022
Director
Exercised, kept
20,000
$85.59
$1.71M
R Sanders Williams
23 May 2022
Director
Sell
600
$250.00
$150.00K
Jonathan P Graham
10 May 2022
EVP, Gen. Counsel & Secy.
Sell
13,500
$241.81
$3.26M
Ronald D Sugar
12 May 2021
Director
Sold after exercise
1,000
$250.59
$250.59K
Nancy A. Grygiel
11 May 2021
SVP & CCO
Sold after exercise
2,500
$252.51
$631.27K
R Sanders Williams
7 May 2021
Director
Sell
250
$251.78
$62.95K
Ronald D Sugar
14 Apr 2021
Director
Sold after exercise
1,000
$249.98
$249.98K
Ronald D Sugar
10 Mar 2021
Director
Sold after exercise
1,000
$231.53
$231.53K
Robert A Bradway
18 Feb 2021
Chairman, CEO and President
Exercised, kept
73,500
$54.69
$4.02M
David M Reese
16 Feb 2021
EVP, Research and Development
Exercised, kept
2,300
$54.69
$125.79K
Ronald D Sugar
10 Feb 2021
Director
Sold after exercise
1,000
$238.40
$238.40K
R Sanders Williams
8 Feb 2021
Director
Sell
250
$237.99
$59.50K
Jonathan P Graham
4 Feb 2021
EVP, Gen. Counsel & Secy.
Sell
11,110
$236.51
$2.63M
Ronald D Sugar
13 Jan 2021
Director
Sold after exercise
1,000
$235.99
$235.99K
R Sanders Williams
9 Nov 2020
Director
Sell
250
$242.40
$60.60K
Ronald D Sugar
19 Aug 2020
Director
Sold after exercise
1,000
$241.02
$241.02K
R Sanders Williams
7 Aug 2020
Director
Sell
250
$242.95
$60.74K
Ronald D Sugar
22 Jul 2020
Director
Sold after exercise
1,000
$259.79
$259.79K
Ronald D Sugar
17 Jun 2020
Director
Sold after exercise
1,000
$228.54
$228.54K
Ronald D Sugar
20 May 2020
Director
Sold after exercise
1,000
$229.27
$229.27K
R Sanders Williams
6 May 2020
Director
Sell
425
$237.31
$100.86K
Ronald D Sugar
22 Apr 2020
Director
Sold after exercise
1,000
$233.35
$233.35K
Robert A Bradway
13 Apr 2020
Chairman, CEO and President
Exercised, kept
84,000
$58.43
$4.91M
Robert A Bradway
13 Apr 2020
Chairman, CEO and President
Exercised, kept
43,000
$58.43
$2.51M
David Piacquad
6 Feb 2020
SVP, Business Development
Sell
9,264
$229.93
$2.13M
R Sanders Williams
6 Feb 2020
Director
Sell
425
$233.72
$99.33K
David W Meline
25 Nov 2019
EVP & CFO
Sell
8,737
$234.36
$2.05M
Jonathan P Graham
22 Nov 2019
EVP, Gen. Counsel & Secy.
Sell
9,000
$230.54
$2.07M
David Piacquad
20 Nov 2019
SVP, Business Development
Exercised, kept
5,749
$156.35
$898.86K
Ronald D Sugar
6 Nov 2019
Director
Sold after exercise
2,000
$215.45
$430.90K
R Sanders Williams
6 Nov 2019
Director
Sell
425
$215.45
$91.57K
Ronald D Sugar
2 Oct 2019
Director
Sold after exercise
2,000
$193.58
$387.16K
Ronald D Sugar
4 Sep 2019
Director
Sold after exercise
2,000
$206.70
$413.40K
Cynthia M Patton
30 Aug 2019
SVP & CCO
Sold after exercise
4,802
$208.07
$999.14K
Cynthia M Patton
30 Aug 2019
SVP & CCO
Sold after exercise
2,875
$208.07
$598.19K
Cynthia M Patton
30 Aug 2019
SVP & CCO
Sold after exercise
5,749
$208.07
$1.20M
Ronald D Sugar
7 Aug 2019
Director
Sold after exercise
2,000
$183.04
$366.08K
R Sanders Williams
7 Aug 2019
Director
Sell
425
$183.04
$77.79K
Ronald D Sugar
3 Jul 2019
Director
Sold after exercise
2,000
$187.58
$375.16K
Ronald D Sugar
5 Jun 2019
Director
Sold after exercise
2,000
$175.68
$351.36K
Ronald D Sugar
1 May 2019
Director
Sold after exercise
2,000
$175.73
$351.46K
Ronald D Sugar
3 Apr 2019
Director
Sold after exercise
2,000
$193.18
$386.36K
Ronald D Sugar
6 Mar 2019
Director
Sold after exercise
2,000
$188.88
$377.76K
Ronald D Sugar
7 Feb 2019
Director
Sold after exercise
2,000
$190.00
$380.00K
Tyler Jacks
6 Dec 2018
Director
Sold after exercise
20,000
$195.41
$3.91M
David Piacquad
30 Nov 2018
SVP, Business Development
Exercised, kept
6,500
$54.69
$355.49K
Cynthia M Patton
29 Nov 2018
SVP & CCO
Sold after exercise
1,777
$202.88
$360.52K
Rebecca M Henderson
10 Aug 2018
Director
Exercised, kept
3,000
$63.11
$189.33K
Sean E Harper
16 Jul 2018
EVP, Research & Development
Sell
1,525
$195.71
$298.46K
Sean E Harper
12 Jun 2018
EVP, Research & Development
Sell
1,525
$184.27
$281.01K
Sean E Harper
14 May 2018
EVP, Research & Development
Sell
1,525
$174.10
$265.50K
David Piacquad
11 May 2018
SVP, Business Development
Exercised, kept
15,000
$54.71
$820.65K
Sean E Harper
12 Apr 2018
EVP, Research & Development
Sell
1,525
$172.68
$263.34K
Sean E Harper
16 Mar 2018
EVP, Research & Development
Sell
1,525
$189.75
$289.37K
Sean E Harper
14 Feb 2018
EVP, Research & Development
Sell
1,525
$174.18
$265.62K
Sean E Harper
16 Jan 2018
EVP, Research & Development
Sell
1,525
$185.62
$283.07K
Sean E Harper
12 Dec 2017
EVP, Research & Development
Sell
1,525
$176.83
$269.67K
Sean E Harper
13 Nov 2017
EVP, Research & Development
Sell
1,525
$171.58
$261.66K
Carbonnel Francois de
8 Nov 2017
Director
Sell
4,000
$173.61
$694.42K
Sean E Harper
9 Oct 2017
EVP, Research & Development
Sell
1,525
$185.95
$283.57K
David Baltimore
31 May 2017
Director
Sell
3,700
$153.93
$569.54K
Cynthia M Patton
24 May 2017
SVP & CCO
Sell
2,922
$154.40
$451.16K

What was left out

Form 4 filings counted 780
Amendments (4/A) skipped 0
Filings about a different issuer 10
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 39
Sales at will 47
Transactions with no price 0
Shares from compensation/vesting 3,398,323
Sales filed before the plan box existed 31
History held since 4 Oct 2006